Description
Aimed at "drug discoverers" - i.e. any scientist who is interested in neurodegenerative diseases in general, and in finding disease-modifying treatments in particular - the first edition of Molecular Targets in Protein Misfolding and Neurodegenerative Disease will contain both a detailed, discipline-specific coverage (paragraphs on medicinal chemistry, on clinical and preclinical characterization of compounds in development, on target identification and validation, on genetic factors influencing a pathology, etc.) and a drug discovery-oriented, overall evaluation of each target (validation, druggability, existing leads, etc.). Together these will satisfy the needs of various audiences, including in vitro biologists, pharmacologists, medicinal chemists, etc.
An extensive reference on the molecular targets, disease-modifying chemical leads, and drugs that exist for neurodegenerative diseases, with a focus on Alzheimer's, tauopathies, and other misfolding diseases.
About the Author
Dr. Pierfausto Seneci is Associate Professor in the Department of Organic and Industrial Chemistry at the University of Milan. He is currently affiliated with the University of Milan Centre for Interdisciplinary Biomolecular Studies and Industrial Applications (CISI) Centre of Excellence, and is responsible for the Combinatorial Chemistry/High Throughput MedChem Laboratory. He has over 20 years of medicinal chemistry experience working in industry, and held business development positions with GSK, Sanofi, and start-up pharmaceutical companies including Sirenade and NiKem working in drug discovery, neurodegeneration, oncology, and antibacterials. He is author of approximately 80 papers on the topic and several book chapters, including the book "Solid-Phase Synthesis and Combinatorial Technologies" with Wiley-Interscience in 2000.
Reviews
"...an excellent biology-oriented discussion of the role of protein misfolding in neurodegenerative diseases...along with the forthcoming companion book, will provide neuroscientists with a strong foundation in this very important topic. Score: 88 - 3 Stars" --Doody's
Book Information
ISBN 9780128001868
Author Pierfausto Seneci
Format Hardback
Page Count 314
Imprint Academic Press Inc
Publisher Elsevier Science Publishing Co Inc
Weight(grams) 1260g
An extensive reference on the molecular targets, disease-modifying chemical leads, and drugs that exist for neurodegenerative diseases, with a focus on Alzheimer's, tauopathies, and other misfolding diseases.
About the Author
Dr. Pierfausto Seneci is Associate Professor in the Department of Organic and Industrial Chemistry at the University of Milan. He is currently affiliated with the University of Milan Centre for Interdisciplinary Biomolecular Studies and Industrial Applications (CISI) Centre of Excellence, and is responsible for the Combinatorial Chemistry/High Throughput MedChem Laboratory. He has over 20 years of medicinal chemistry experience working in industry, and held business development positions with GSK, Sanofi, and start-up pharmaceutical companies including Sirenade and NiKem working in drug discovery, neurodegeneration, oncology, and antibacterials. He is author of approximately 80 papers on the topic and several book chapters, including the book "Solid-Phase Synthesis and Combinatorial Technologies" with Wiley-Interscience in 2000.
Reviews
"...an excellent biology-oriented discussion of the role of protein misfolding in neurodegenerative diseases...along with the forthcoming companion book, will provide neuroscientists with a strong foundation in this very important topic. Score: 88 - 3 Stars" --Doody's
Book Information
ISBN 9780128001868
Author Pierfausto Seneci
Format Hardback
Page Count 314
Imprint Academic Press Inc
Publisher Elsevier Science Publishing Co Inc
Weight(grams) 1260g
